These new medications, like copyright and Semaglutide, represent a significant class of drugs called GLP-1 receptor mimics. They work by enhancing the body's natural ability to produce GLP-1, a hormone that helps regulate glucose levels and hunger. Initially, designed for treating type 2 diabetes mellitus, they have also shown effectiveness in aidi

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide works as a glucagon-like peptide-1 (GLP-1) receptor agonist. Thi